This meta-analysis looked at how a specific type of spinal cord stimulation, called ECAP-controlled closed-loop SCS, affects people with chronic neuropathic pain. The study included data from 453 adults who were experiencing long-term nerve pain.
The results showed that 90% of patients reported at least a 50% reduction in their pain levels. Additionally, many patients saw improvements in their daily functions and overall quality of life. About 77% of the participants were able to reduce or eliminate their use of opioid medications, while 66% reported better sleep.
While the results are positive, it is important to note that this analysis included both randomized trials and observational studies. Some parts of the data showed high variation between different studies. Most side effects reported were mild and related to the device itself. You should talk with your doctor to see if this specific treatment is a safe and appropriate option for your personal health needs.
Common questions
How effective is this type of spinal cord stimulation?
The study found that 90% of patients experienced at least a 50% reduction in their pain. Additionally, about 57% of patients reported a high pain response of 80% or more. These results suggest the treatment provides consistent relief for many people with chronic nerve pain.
Can this treatment help with other issues like sleep or medication use?
Yes, the study showed that 66% of patients reported improved sleep and 77% were able to reduce or eliminate their use of opioid medications. Most patients also reported high levels of satisfaction with the treatment, with a 98% satisfaction rate recorded.
Is this spinal cord stimulation safe for patients?
The study reported an acceptable safety profile. Most complications were mild and related to the device itself rather than the procedure. Serious adverse events were noted as rare, making it a generally well-tolerated option for those seeking relief from neuropathic pain.
